Page 217 - Liver Diseases in Children

ไวรัสตับอักเสบ 207

pthaigastro.org
42. Theamboonlers A, Hansurabhanon T, Verachai V, Chongsrisawat V, Poovorawan Y. Hepatitis D
virus infection in Thailand: HDV genotyping by RT-PCR, RFLP and direct sequencing. Infection
2002;30:140-4.

43. Noureddin M, Gish R. Hepatitis delta: epidemiology, diagnosis and management 36 years after
discovery. Curr Gastroenterol Rep 2014;16:365.
44. Wasitthankasem R, Posuwan N, Vichaiwattana P, Theamboonlers A, Klinfueng S, Vuthitanachot V, et al.
Decreasing hepatitis C virus infection in Thailand in the past decade: evidence from the 2014 National
Survey. PLoS One 2016;11:e0149362.
45. Sunanchaikarn S, Theamboonlers A, Chongsrisawat V, Yoocharoen P, Tharmaphornpilas P, Warinsathien
P, et al. Seroepidemiology and genotypes of hepatitis C virus in Thailand. Asian Pac J Allergy Immunol
2007;25:175-82.
46. Yeung CY, Lee HC, Chan WT, Jiang CB, Chang SW, Chuang CK. Vertical transmission of hepatitis C
virus: current knowledge and perspectives. World J Hepatol 2014;6:643-51.
47. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of

vertically acquired hepatitis C virus infection. Clin Infect Dis 2005;41:45-51.
48. Guido M, Bortolotti F, Leandro G, Jara P, Hierro L, Larrauri J, et al. Fibrosis in chronic hepatitis C
acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003;98:660-3.
49. Mohan P, Colvin C, Glymph C, Chandra RR, Kleiner DE, Patel KM, et al. Clinical spectrum and
histopathologic features of chronic hepatitis C infection in children. J Pediatr 2007;150:168-74, 74.e1.
50. Indolfi G, Hierro L, Dezsofi A, Jahnel J, Debray D, Hadzic N, et al. Treatment of chronic hepatitis C virus
infection in children: a position paper by the Hepatology Committee of European Society of Paediatric
Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;66:505-15.
51. Haber B, Alonso E, Pedreira A, Rodriguez-Baez N, Ciocca M, Lacaille F, et al. Long-term follow-up of
children treated with peginterferon and ribavirin for hepatitis C virus Infection. J Pediatr Gastroenterol
Nutr 2017;64:89-94.
52. Ponziani FR, Mangiola F, Binda C, Zocco MA, Siciliano M, Grieco A, et al. Future of liver disease in the
era of direct acting antivirals for the treatment of hepatitis C. World J Hepatol 2017;9:352-67.

53. Indolfi G, Serranti D, Resti M. Direct-acting antivirals for children and adolescents with chronic hepatitis
C. Lancet Child Adolesc Health 2018;2:298-304.
54. Wirth S, Rosenthal P, Gonzalez-Peralta RP, Jonas MM, Balistreri WF, Lin CH, et al. Sofosbuvir and
ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology
2017;66:1102-10.
55. Barshes NR, Udell IW, Lee TC, O’Mahony CA, Karpen SJ, Carter BA, et al. The natural history of
hepatitis C virus in pediatric liver transplant recipients. Liver Transpl 2006;12:1119-23.